BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fu YS, Ho WY, Kang N, Tsai MJ, Wu J, Huang L, Weng CF. Pharmaceutical Prospects of Curcuminoids for the Remedy of COVID-19: Truth or Myth. Front Pharmacol 2022;13:863082. [PMID: 35496320 DOI: 10.3389/fphar.2022.863082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu YQ, Tong T. Curcumae Rhizoma: A botanical drug against infectious diseases. Front Pharmacol 2022;13:1015098. [PMID: 36703758 DOI: 10.3389/fphar.2022.1015098] [Reference Citation Analysis]
2 Chen TH, Tsai MJ, Chang CS, Xu L, Fu YS, Weng CF. The exploration of phytocompounds theoretically combats SARS-CoV-2 pandemic against virus entry, viral replication and immune evasion. J Infect Public Health 2023;16:42-54. [PMID: 36470006 DOI: 10.1016/j.jiph.2022.11.022] [Reference Citation Analysis]
3 Pisoschi AM, Iordache F, Stanca L, Gajaila I, Ghimpeteanu OM, Geicu OI, Bilteanu L, Serban AI. Antioxidant, Anti-inflammatory, and Immunomodulatory Roles of Nonvitamin Antioxidants in Anti-SARS-CoV-2 Therapy. J Med Chem 2022. [PMID: 36136726 DOI: 10.1021/acs.jmedchem.2c01134] [Reference Citation Analysis]
4 Wu J, Fu YS, Lin K, Huang X, Chen YJ, Lai D, Kang N, Huang L, Weng CF. A narrative review: The pharmaceutical evolution of phenolic syringaldehyde. Biomed Pharmacother 2022;153:113339. [PMID: 35780614 DOI: 10.1016/j.biopha.2022.113339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]